Search results
Results from the WOW.Com Content Network
A euthanasia solution is a drug-containing aqueous solution for intentionally ending life to either relieve pain and suffering or execute convicts. [1] The drugs used in euthanasia solution do not only need to be safe to personnel, but they also need to have a rapid onset of action and minimize the possible pain felt by humans and animals. [2]
Human. Secobarbital is used in assisted dying, either euthanasia or palliative sedation. [8] [9] [10]In the Netherlands, individuals have two options for assisted dying: they can orally consume 100 mL of concentrated syrup containing either 15 grams of pentobarbital or 15 grams of secobarbital, or they can choose to have 2 grams of thiopental or 1 gram of propofol administered intravenously by ...
Pentobarbital has been used or considered as a substitute for the barbiturate sodium thiopental used for capital punishment by lethal injection in the United States when that drug became unavailable. [16] In 2011 the U.S. manufacturer of sodium thiopental stopped production, and importation of the drug proved impossible.
Pentobarbital, often used for animal euthanasia, [57] was used as part of a three-drug cocktail for the first time on December 16, 2010, when John David Duty was executed in Oklahoma. [51] It was then used as the drug in a single-drug execution for the first time on March 10, 2011, when Johnnie Baston was executed in Ohio. [58]
A 2002 study of hospice nurses and social workers in Oregon reported that symptoms of pain, depression, anxiety, extreme air hunger and fear of the process of dying were more pronounced among hospice patients who did not request a lethal prescription for barbiturates, the drug used for physician-assisted death. [219]
Photo Illustration by Thomas Levinson/The Daily Beast/Getty; Biwer et al.Throughout the Andes, stretching skyward from dry tropical rainforests, is an inconspicuous tree that can turn your mind ...
Embutramide (INN, USAN, BAN; brand name Embutane) is a potent sedative drug that is structurally related to GHB. [1] [2] [3] It was developed by Hoechst A.G. in 1958 [4] and was investigated as a general anesthetic agent, but was found to have a very narrow therapeutic window, with a 50 mg/kg dose producing effective sedation and a 75 mg/kg dose being fatal.
The death of an unnamed 64-year-old woman from the U.S. Midwest led to multiple arrests after she became the first person to use the “Sarco” pod—a high-tech device promising a “peaceful ...